The result is a stronger overall effect, helping you feel fuller, reduce cravings, and use stored fat more efficiently for energy
Other research has highlighted its protective effects on the gastrointestinal (GI) tract, including accelerated healing of ulcers and mitigated damage from toxins
Please contact us today with any additional questions you may have, or to schedule a consultation.
Helpful policy pages may include [Internal Link: Quality and Testing Standards]
The SUSTAIN-1 phase 3 trial demonstrated the safety and tolerability of once-weekly semaglutide injection as monotherapy in patients with type 2 diabetes, achieving reduction in HbA1c of 1.55% at the highest dose of semaglutide, 1 mg vs
Moiz and colleagues found that retatrutide 12 mg weekly (Eli Lilly) showed the greatest effect on obesity among all agents in the review, producing weight loss of up to 22.1% (95% CI, 19.3%-24.9%) after 48 weeks of treatment